Rajat Bose of rajatkbose.com told CNBC-TV18, "Cadila Healthcare has long been my favourite. I have been giving medium-term positional calls and also intraday calls. I continue to like that and it has actually bounced back from the levels that I expected it to. For today Rs 355 should be your stoploss and I am expecting Rs 379 to about 393; Rs 393 happens to be a strong resistances for Cadila. If it is taken out then it would be headed higher for today.""Overall the medium-term, the target for Cadila remains at Rs 450 and once that is taken out it could even go up to Rs 540. I am pretty bullish, I have recommended it to my clients, that is a disclosure from my side. No personal holdings as yet," he added."In Sun Pharma Advanced Research Company (SPARC) put a stoploss below Rs 375, Rs 406 and 425 are the two targets. When it gets momentum it could actually achieve those targets even today. However, it looks excellent on the charts," he said.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
